Concentrations and Credit Risks	3 Months Ended
Mar. 31, 2019
Risks and Uncertainties [Abstract]
CONCENTRATIONS AND CREDIT RISKS	NOTE 9 – CONCENTRATIONS AND CREDIT RISKS Financial instruments that subjected the Company to concentrations of market risk consisted principally of equity investments, at fair value, which collectively represented approximately 35.2% and 25.2% of the Company's total assets at March 31, 2019 and December 31, 2018, respectively. These investments are valued in accordance with the Company's fair value policies and procedures. At March 31, 2019 and December 31, 2018, all of the fair value of the Company's equity investments, at fair value is concentrated in one entity in the biometric technology industry, which gives rise to a risk of significant loss should the performance or financial condition of this industry or the portfolio company deteriorates.

The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-URI http://asc.fasb.org/topic&trid=2134479

Name:	us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration